Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB26FX1KY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,137
Award facts
- Contract value 100% obligated
- $49,137.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $49,137.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The contract contains no set-aside designation, indicating the award was made through full and open competition. DMS Pharmaceutical Group, which has maintained SAM registration since 2001, will perform the work at its Park Ridge facility with an ultimate completion date of November 28, 2025.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, valued at $499.9 million with a completion date of December 31, 2036, authorizes the DLA to issue delivery orders for comprehensive pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established track record supplying specialized oncology treatments and other critical pharmaceuticals to military healthcare facilities demonstrates its capability to fulfill this oncology drug requirement as part of the broader federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FX1KY?
SPE2DB26FX1KY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FX1KY worth?
The government has obligated $49,137 on SPE2DB26FX1KY.
Is contract SPE2DB26FX1KY an order under another contract?
Yes. SPE2DB26FX1KY is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1KY competed?
The extent of competition for SPE2DB26FX1KY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award